We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLD
526
DELISTED
TopBuild
BLD
| $21M | 0.03% |
324,033
+1,862
| +0.6% | +$105K |
|
|
JWN
527
DELISTED
Nordstrom
JWN
| $20.8M | 0.03% |
468,836
-77,070
| -14% | -$3.52M |
|
|
HES
528
DELISTED
Hess
HES
| $20.8M | 0.03% |
345,315
-32,601
| -9% | -$1.79M |
|
529
CVS Health
CVS
$138B
| $20.8M | 0.03% |
385,091
+154,644
| +67% | +$9.54M |
|
|
PBFX
530
DELISTED
PBF LOGISTICS LP
PBFX
| $20.7M | 0.03% |
985,940
-14,904
| -1% | -$322K |
|
531
HP
HPQ
$23B
| $20.7M | 0.03% |
1,063,520
-565,045
| -35% | -$12M |
|
532
Dollar Tree
DLTR
$23.5B
| $20.6M | 0.03% |
196,397
+67,238
| +52% | +$6.6M |
|
533
SFL Corp
SFL
$1.51B
| $20.6M | 0.03% |
1,668,540
+9,737
| +0.6% | +$118K |
|
534
TotalEnergies
TTE
$189B
| $20.4M | 0.03% |
367,315
-12,820
| -3% | -$713K |
|
|
ATVI
535
DELISTED
Activision Blizzard
ATVI
| $20.3M | 0.03% |
446,601
-1,235,656
| -73% | -$55.8M |
|
536
Bank of N.T. Butterfield & Son
NTB
$2.4B
| $20.2M | 0.03% |
563,665
+11,544
| +2% | +$415K |
|
|
SUM
537
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $20.1M | 0.03% |
1,291,072
+26,481
| +2% | +$414K |
|
538
Mid-America Apartment Communities
MAA
$15.3B
| $20.1M | 0.03% |
183,827
-38,001
| -17% | -$3.91M |
|
539
CBRE Group
CBRE
$40.1B
| $20M | 0.02% |
405,237
-81,482
| -17% | -$3.83M |
|
540
Okta
OKTA
$23.8B
| $20M | 0.02% |
241,904
+24,851
| +11% | +$1.97M |
|
541
DexCom
DXCM
$27.6B
| $19.9M | 0.02% |
668,044
+135,208
| +25% | +$4.75M |
|
542
Molina Healthcare
MOH
$11.6B
| $19.8M | 0.02% |
139,769
-52,507
| -27% | -$7.1M |
|
543
Inogen
INGN
$176M
| $19.8M | 0.02% |
207,914
-100,468
| -33% | -$12.5M |
|
544
Azenta
AZTA
$1.25B
| $19.8M | 0.02% |
674,739
+14,931
| +2% | +$449K |
|
545
QuidelOrtho
QDEL
$1.14B
| $19.4M | 0.02% |
296,365
+5,088
| +2% | +$308K |
|
546
McKesson
MCK
$95.3B
| $19.4M | 0.02% |
165,652
+20,661
| +14% | +$2.55M |
|
547
Emergent Biosolutions
EBS
$391M
| $19.4M | 0.02% |
383,787
+10,804
| +3% | +$637K |
|
548
TransUnion
TRU
$14.5B
| $19.2M | 0.02% |
287,413
-196,881
| -41% | -$12.2M |
|
|
TCF
549
DELISTED
TCF Financial Corporation Common Stock
TCF
| $19.1M | 0.02% |
464,807
+10,322
| +2% | +$447K |
|
550
Kroger
KR
$35.3B
| $19M | 0.02% |
773,011
+62,097
| +9% | +$1.7M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.